Clinical Trials at Fred Hutch/University of Washington Cancer Consortium

As of July 2026, 83 paid clinical trials are recruiting at Fred Hutch/University of Washington Cancer Consortium, located at Fred Hutch Cancer Center at UW Medical Center - Montlake, 1959 NE Pacific St, Seattle, WA 98195, phone (206) 598-3300 in Seattle, Washington. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 17, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

89 clinical trials at Fred Hutch/University of Washington Cancer Consortium

·Clear filters·↓ Download CSV

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

for Acute Myeloid Leukemia

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT06928662·Phase 1, Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease

for Chronic Graft Versus Host Disease

Sites in Seattle +4 more locations

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18+

Code: NCT05996627·Phase 2·Recruiting·Listed Aug 2023

Apply to this trial

[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer

for Anatomic Stage IV Breast Cancer AJCC v8

1 location in Seattle

Sponsor: University of Washington

Sex: All·Age: 18+

Code: NCT06502691·Phase 1, Phase 2·Recruiting·Listed Jul 2024

Apply to this trial

Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer

for Anatomic Stage I Breast Cancer AJCC v8

1 location in Seattle

Sponsor: University of Washington

Sex: All·Age: 18+

Code: NCT04329065·Phase 2·Recruiting·Listed Apr 2020

Apply to this trial

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

for Juvenile Myelomonocytic Leukemia

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: Up to 80

Code: NCT03326921·Phase 1·Recruiting·Listed Oct 2017

Apply to this trial

Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, The AVENUE-2 Trial

for Recurrent Chronic Lymphocytic Leukemia

Drug: Venetoclax

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18+

Code: NCT04941716·Phase 2·Recruiting·Listed Jun 2021

Apply to this trial

A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer

for Anatomic Stage IV Breast Cancer AJCC v8

1 location in Seattle

Sponsor: University of Washington

Sex: All·Age: 18+

Code: NCT07112053·Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study

for Prostate Carcinoma

Sites in Seattle +6 more locations

Sponsor: University of Washington

Sex: Male·Age: 40+·Accepts healthy volunteers

Code: NCT04472338·Recruiting·Listed Jul 2020

Apply to this trial

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

for Acute Biphenotypic Leukemia

Sites in Seattle +8 more locations

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 6 Months - 26·Accepts healthy volunteers

Code: NCT03779854·Phase 2·Recruiting·Listed Dec 2018

Apply to this trial

Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T

for Recurrent Diffuse Large B-Cell Lymphoma

Drug: Odronextamab

1 location in Seattle

Sponsor: University of Washington

Sex: All·Age: 18+

Code: NCT06784726·Phase 2·Recruiting·Listed Jan 2025

Apply to this trial

A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer

for Anatomic Stage IV Breast Cancer AJCC v8

1 location in Seattle

Sponsor: University of Washington

Sex: All·Age: 18+

Code: NCT07078604·Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

Sustained Oral Fiber Supplementation for Patients Undergoing Donor Stem Cell Transplantation for Hematological Malignancies

for Hematopoietic and Lymphatic System Neoplasm

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18+

Code: NCT04829136·Recruiting·Listed Apr 2021

Apply to this trial

Pacritinib With Standard of Care Azacitidine or Decitabine as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant for Patients With Accelerated and Blast Phase Myeloproliferative Neoplasms

for Accelerated Phase Myeloproliferative Neoplasm

Drug: Pacritinib

1 location in Seattle

Sponsor: University of Washington

Sex: All·Age: 18+

Code: NCT07148947·Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma

for Chronic Lymphocytic Leukemia

Drug: Sonrotoclax

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18+

Code: NCT06839053·Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer Survivors

for Stage II Colorectal Cancer AJCC v8

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18 - 70

Code: NCT05930496·Recruiting·Listed Jul 2023

Apply to this trial

Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study

for Recurrent Fallopian Tube Carcinoma

1 location in Seattle

Sponsor: University of Washington

Sex: All·Age: All ages

Code: NCT06295965·Recruiting·Listed Mar 2024

Apply to this trial

Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms

for Acute Biphenotypic Leukemia

Drug: Venetoclax

1 location in Seattle

Sponsor: University of Washington

Sex: All·Age: 18+

Code: NCT04797767·Phase 1, Phase 2·Recruiting·Listed Mar 2021

Apply to this trial

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

for Anatomic Stage III Breast Cancer AJCC v8

Sites in Seattle +1 more location

Sponsor: University of Washington

Sex: All·Age: 18+

Code: NCT06179303·Phase 2·Recruiting·Listed Dec 2023

Apply to this trial

Axatilimab for Sclerotic Chronic Graft-versus-Host Disease

for Chronic Graft Versus Host Disease

Sites in Seattle +2 more locations

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18+

Code: NCT07011810·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

for Acute Myeloid Leukemia

Drug: Ruxolitinib

1 location in Seattle

Sponsor: University of Washington

Sex: All·Age: 18+

Code: NCT04282187·Phase 2·Recruiting·Listed Feb 2020

Apply to this trial

Low Dose Mosunetuzumab for the Treatment of Patients With Indolent B-Cell Lymphoma

for Ann Arbor Stage II Follicular Lymphoma

Drug: Mosunetuzumab

1 location in Seattle

Sponsor: University of Washington

Sex: All·Age: 18+

Code: NCT06442475·Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

for Acute Leukemia

Sites in Seattle +2 more locations

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 1 - 60

Code: NCT03970096·Phase 2·Recruiting·Listed May 2019

Apply to this trial

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders

for Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: Up to 50

Code: NCT03980769·Phase 2·Recruiting·Listed Jun 2019

Apply to this trial

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

for Anatomic Stage IV Breast Cancer AJCC v8

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18+

Code: NCT05098210·Phase 1·Recruiting·Listed Oct 2021

Apply to this trial

Fecal Microbiota Transplant and Dietary Fiber Supplementation for the Treatment of Gut Graft Versus Host Disease

for Intestinal Graft Versus Host Disease

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18+

Code: NCT05067595·Phase 1·Recruiting·Listed Oct 2021

Apply to this trial

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

for Recurrent Acute Myeloid Leukemia

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18+

Code: NCT04375631·Phase 1·Recruiting·Listed May 2020

Apply to this trial

Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education

for Stage I Colorectal Cancer AJCC v8

2 locations in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18+

Code: NCT06995924·Recruiting·Listed May 2025

Apply to this trial

Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma

for Aggressive Non-Hodgkin Lymphoma

Drug: Polatuzumab Vedotin

1 location in Seattle

Sponsor: University of Washington

Sex: All·Age: 18+

Code: NCT04231877·Phase 1·Recruiting·Listed Jan 2020

Apply to this trial

ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell Lymphoma

for Recurrent Diffuse Large B-Cell Lymphoma

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18+

Code: NCT07098364·Phase 1, Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial

for Bladder Cancer

1 location in Seattle

Sponsor: University of Washington

Sex: All·Age: 18+

Code: NCT06040762·Recruiting·Listed Sep 2023

Apply to this trial

Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer

for Acute Leukemia of Ambiguous Lineage

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18+

Code: NCT07046078·Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer

for Castration-Resistant Prostate Carcinoma

Sites in Seattle +2 more locations

Sponsor: University of Washington

Sex: Male·Age: 18+

Code: NCT04489719·Recruiting·Listed Jul 2020

Apply to this trial

Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia

for Acute Myeloid Leukemia

1 location in Seattle

Sponsor: University of Washington

Sex: All·Age: 18+

Code: NCT06710418·Recruiting·Listed Nov 2024

Apply to this trial

A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking, IndigeQuit Trial

for Cigarette Smoking-Related Carcinoma

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT06145763·Recruiting·Listed Nov 2023

Apply to this trial

Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer

for Castration-Resistant Prostate Carcinoma

Drug: Vorinostat

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: Male·Age: All ages

Code: NCT06145633·Phase 2·Recruiting·Listed Nov 2023

Apply to this trial

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

for Acute Leukemia of Ambiguous Lineage

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 6 Months - 65

Code: NCT06013423·Phase 2·Recruiting·Listed Aug 2023

Apply to this trial

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

for Localized Renal Pelvis and Ureter Urothelial Carcinoma

1 location in Seattle

Sponsor: University of Washington

Sex: Male·Age: 18+·Accepts healthy volunteers

Code: NCT01050504·Recruiting·Listed Jan 2010

Apply to this trial

PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer

for Metastatic Lung Non-Small Cell Carcinoma

1 location in Seattle

Sponsor: University of Washington

Sex: All·Age: 18+

Code: NCT04151940·Recruiting·Listed Nov 2019

Apply to this trial

Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study

for Castration-Resistant Prostate Carcinoma

1 location in Seattle

Sponsor: University of Washington

Sex: Male·Age: 18+

Code: NCT06039371·Phase 2·Recruiting·Listed Sep 2023

Apply to this trial

Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis

for Primary Myelofibrosis

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18 - 70

Code: NCT04370301·Phase 2·Recruiting·Listed Apr 2020

Apply to this trial